Evaluating [225Ac]Ac-FAPI-46 for the Treatment of Soft-Tissue Sarcoma in Mice

The authors investigated the anti-tumor efficacy of [225Ac]Ac-FAPI-46 as monotherapy or in combination with immune checkpoint blockade (ICB) in immunocompetent murine models of sarcoma sensitive or resistant to ICB.